GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Gross-Profit-to-Asset %

Biosino Bio-Technology and Science (HKSE:08247) Gross-Profit-to-Asset % : 18.09% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Biosino Bio-Technology and Science's annualized Gross Profit for the quarter that ended in Dec. 2023 was HK$111.4 Mil. Biosino Bio-Technology and Science's average Total Assets over the quarter that ended in Dec. 2023 was HK$616.1 Mil. Therefore, Biosino Bio-Technology and Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 18.09%.


Biosino Bio-Technology and Science Gross-Profit-to-Asset % Historical Data

The historical data trend for Biosino Bio-Technology and Science's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Gross-Profit-to-Asset % Chart

Biosino Bio-Technology and Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.44 17.98 23.69 23.04 21.60

Biosino Bio-Technology and Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.20 21.60 24.06 23.93 18.09

Competitive Comparison of Biosino Bio-Technology and Science's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosino Bio-Technology and Science's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Biosino Bio-Technology and Science's Gross-Profit-to-Asset % falls into.



Biosino Bio-Technology and Science Gross-Profit-to-Asset % Calculation

Biosino Bio-Technology and Science's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=139.309/( (673.651+616.072)/ 2 )
=139.309/644.8615
=21.60 %

Biosino Bio-Technology and Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=111.444/( (0+616.072)/ 1 )
=111.444/616.072
=18.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Biosino Bio-Technology and Science Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosino Bio-Technology and Science (HKSE:08247) Business Description

Traded in Other Exchanges
N/A
Address
No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.
Executives
Beijing Enterprises Group Company Limited 2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited 2101 Beneficial owner
Hk Zhixin Investment Co., Ltd. 2101 Beneficial owner
Li Dongfeng 2201 Interest of corporation controlled by you
Yan Kang 2201 Interest of corporation controlled by you
Qiu Zhe Feng 2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Li Yang Yi Xiong 2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines